Flunixin Meglumine

Manufacturer
Medisca Inc.
Effective date
2021-10-25
Label type
BULK INGREDIENT
Version
7
Source
legacy-cache
Hydrated at
2026-08-01 22:30:45

Label at a glance#

ProductFlunixin Meglumine
Active ingredientFLUNIXIN MEGLUMINE
Label structure1 sections

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DESCRIPTION: White to off white crystalline powder.

NDC 38779-1934-3

Packed by Medisca Inc.

Plattsburgh, NY, 12901, USA

MEDISCA

TO ORDER CALL 1 (800) 932-1039

FLUNIXIN MEGLUMINE, USP

Caution: Not For Human Use

5 kg

For use and distribution in prescription compounding, manufacturing, processing or repacking only in accordance with FDA regulations and applicable law.

STORAGE: Preserve in well closed containers. Store at 25°C, excursions permitted between 15° and 30°C.

Lot:

Exp:

Cas: 42461-84-7

See Material Safety Data Sheet

label informationlabel information

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
38779-1934-4GM - Gram38779-19344a2c2827-030f-4f10-b762-6d897da1b47212013-08-02
38779-1934-5GM - Gram38779-193488982341-c35c-4b10-8389-069947909a1812013-08-02
38779-1934-9GM - Gram38779-193461341032-0aa7-4ef1-99dc-f5df06efd42c12013-08-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
FLUNIXIN MEGLUMINEACTIVE INGREDIENT8Y3JK0JW3U3
FLUNIXINACTIVE MOIETY356IB1O4003

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
38779-193438779-1934-3, 38779-1934-4, 38779-1934-5, 38779-1934-9

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
FLUNIXIN MEGLUMINE8Y3JK0JW3UACTIB

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.